Showing results (211-220 of 361) with videos related to

Sort By:
Pageof 37
American Journal of Clinical Oncology|January 22, 2002
Thymidylate synthase expression in stage II and III colon cancer: a retrospective reviewA Tomiak, M Vincent, C C Earle, et al.
Leukemia & Lymphoma|July 8, 2008
Delays in referral and diagnosis for chronic hematologic malignancies: a literature reviewGregory A Abel, Christopher R Friese, Lysa S Magazu, et al.
Canadian Family Physician Medecin De Famille Canadien|April 15, 2021
Building capacity for palliative care delivery in primary care settings: Mixed-methods evaluation of the INTEGRATE ProjectJenna M Evans, Marnie Mackinnon, José Pereira, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 29, 2019
Low rates of specialized cancer consultation and cancer-directed therapy for noncurable pancreatic adenocarcinoma: a population-based analysisMichail N Mavros, Natalie G Coburn, Laura E Davis, et al.
Journal of Pain and Symptom Management|November 24, 2022
The Effect of Specialized Palliative Care on End-of-Life Care Intensity in AYAs with CancerNatalie Jewitt, Adam Rapoport, Abha Gupta, et al.
Cancer Treatment and Research Communications|December 28, 2020
Salvage surgery for locally recurrent anal cancer after intensity modulated radiation therapy with concurrent chemotherapyJessica Bogach, Darlene Fenech, William Chu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 7, 2020
Impact of Geography on Care Delivery and Survival for Noncurable Pancreatic Adenocarcinoma: A Population-Based AnalysisElliott K Yee, Natalie G Coburn, Laura E Davis, et al.
Cancer Chemotherapy and Pharmacology|February 5, 2010
Phase II study of pemetrexed in patients with advanced neuroendocrine tumorsJennifer A Chan, Andrew X Zhu, Keith Stuart, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 26, 2015
Does routine symptom screening with ESAS decrease ED visits in breast cancer patients undergoing adjuvant chemotherapy?L Barbera, R Sutradhar, D Howell, et al.
BMC Cancer|September 7, 2019
Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocolMonika K Krzyzanowska, Jim A Julian, Melanie Powis, et al.
Pageof 37